Skip to NavigationSkip to content

News

0
Zytiga image
Drug can extend life by over three months
0
Nexavar image
Trial looked at both drugs in patients with advanced kidney cancer
0
Six firms to spend £14.4 million over four years 
0
Erbitux image
Erbitux showed no benefit in disease-free survival

Features

Brazil image

Global pharmaceutical companies are missing a chance to serve Brazil’s prosperous and growing middle class, says McKinsey’s Sanjeev Agarwal

a site by SiftGroups